Literature DB >> 15250671

Folate and homocysteine levels in pregnancy.

M A Megahed1, I M Taher.   

Abstract

This study aims to determine serum folate and plasma homocysteine levels in healthy pregnant women following a live birth and compare them with healthy non-pregnant women. Fifty healthy gravid multiparous women are included in the study and 25 normal non-pregnant female subjects act as controls (group I). The pregnant women are divided into two groups according to interpregnancy interval: group II (six months or less); group III (18-24 months). Venous blood samples are analysed for red blood cell folate and homocysteine, vitamin B12, serum folate and albumin, and serum aminotransferases (ALT and AST). There was a significant decrease in red cell folate and serum folate in group II compared to the control group (P<0.001). Serum vitamin B12 showed no significant difference. Plasma homocysteine and serum albumin showed significant decreases in both groups II and III compared to the control group. (P<0.001) There was significant positive correlation between homocysteine and serum albumin in the three studied groups. (r=0.42, P<0.001; r=0.45, P<0.001; r=0.51, P<0.001, respectively). There was significant negative correlation between red cell folate and homocysteine in the three studied groups. (r=-0.48, P<0.001; r=-0.53, P<0.001; r=-0.49, P<0.001, respectively). Two cases in group II showed signs of intrauterine growth retardation. The results suggest that pregnant females with short interpregnancy intervals are more likely to develop folate deficiency. Educational strategies are required to increase folate awareness among women to promote the benefits of folic acid supplementation. Mandatory folate fortification of foods should be defined and monitored.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250671     DOI: 10.1080/09674845.2004.11732649

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  7 in total

Review 1.  Impact of increasing inter-pregnancy interval on maternal and infant health.

Authors:  Amanda Wendt; Cassandra M Gibbs; Stacey Peters; Carol J Hogue
Journal:  Paediatr Perinat Epidemiol       Date:  2012-07       Impact factor: 3.980

2.  The application of a chemical determination of N-homocysteinylation levels in developing mouse embryos: implication for folate responsive birth defects.

Authors:  Kristin Fathe; Maria D Person; Richard H Finnell
Journal:  J Nutr Biochem       Date:  2014-11-12       Impact factor: 6.048

3.  Homocysteine and folate levels as indicators of cerebrovascular accident.

Authors:  Vo Osunkalu; At Onajole; Ka Odeyemi; Ba Ogunnowo; Ao Sekoni; Ga Ayoola; A Adediran; Or Akinde; At Adeyemo
Journal:  J Blood Med       Date:  2010-07-14

4.  Pregnancy intervals after stillbirth, neonatal death and spontaneous abortion and the risk of an adverse outcome in the next pregnancy in rural Bangladesh.

Authors:  Bareng A S Nonyane; Maureen Norton; Nazma Begum; Rasheduzzaman M Shah; Dipak K Mitra; Gary L Darmstadt; Abdullah H Baqui
Journal:  BMC Pregnancy Childbirth       Date:  2019-02-09       Impact factor: 3.007

5.  The evaluation of serum homocysteine, folic acid, and vitamin B12 in patients complicated with preeclampsia.

Authors:  Nahid Shahbazian; Razieh Mohammad Jafari; Sahar Haghnia
Journal:  Electron Physician       Date:  2016-10-25

6.  Folate, vitamin B12, ferritin and haemoglobin levels among women of childbearing age from a rural district in South India.

Authors:  Samiksha Singh; Jaga Jeevan Babu Geddam; G Bhanuprakash Reddy; Dinesh Raj Pallepogula; Hira Ballabh Pant; Sutapa B Neogi; Neena John; Sunanda Reddy Kolli; Pat Doyle; Sanjay Kinra; Andy Ness; Gudlavalleti Venkata Satyanarayana Murthy
Journal:  BMC Nutr       Date:  2017-06-26

7.  The effect of A1298c polymorphism of the MTHFR gene on anti-Müllerian hormone levels: experimental and Web-based analysis.

Authors:  Seyedeh Zahra Shahrokhi; Faranak Kazerouni; Firouzeh Ghaffari; Morteza Hadizadeh; Zahra Zolfaghary
Journal:  J Clin Lab Anal       Date:  2021-08-08       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.